首页 > 最新文献

Perioperative Medicine最新文献

英文 中文
Analysis of laboratory markers in body contouring procedures after bariatric surgery does not indicate particular risks for perioperative complications. 对减肥手术后身体塑形过程中的实验室指标进行分析,并未发现围手术期并发症的特殊风险。
IF 2 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-27 DOI: 10.1186/s13741-024-00422-7
Maximilian C Stumpfe, Juliane Platzer, Raymund E Horch, Alexander Geierlehner, Andreas Arkudas, Wibke Mueller-Seubert, Aijia Cai, Theresa Promny, Ingo Ludolph

Background: Body contouring surgery after massive weight loss is associated with different risk factors. Wound healing disorders and seromas commonly occur postoperatively. Bariatric interventions lead to massive weight loss with excess skin and soft tissue. In this study, perioperatively collected laboratory markers of this special patient population were analyzed.

Methods: Fifty-nine patients were analyzed retrospectively regarding bariatric surgery, weight loss, body contouring surgery, laboratory markers, and complication rates.

Results: Body contouring surgery (n = 117) was performed in 59 patients. Weight loss was achieved after gastric bypass (40.1%), gastric banding (33.9%), or sleeve gastrectomy (26.0%), with an average of 69.2 kg. The most common body contouring procedure included abdominoplasty (n = 50), followed by thigh lift (n = 29), mammaplasty (n = 19), brachioplasty (n = 14), and upper body lift (n = 5). Analysis of laboratory markers revealed no exceptional and clinically relevant variations. Correlation analysis revealed associations between resection weight, amount of drain fluid, and particular laboratory markers.

Conclusion: Analysis of perioperative laboratory markers in this special patient population after massive weight loss did not indicate clinically relevant risk factors regardless of the type of bariatric or body contouring surgery. Body contouring surgeries after bariatric interventions prove to be safe and low risk concerning perioperative laboratory markers and postoperative hospitalization.

背景:大量减肥后进行身体塑形手术有不同的风险因素。术后通常会出现伤口愈合障碍和血清瘤。减肥手术会导致体重大量减轻,并伴有多余的皮肤和软组织。本研究对这一特殊患者群体围手术期收集的实验室指标进行了分析:方法:对 59 名患者的减肥手术、体重减轻、身体塑形手术、实验室指标和并发症发生率进行回顾性分析:结果:59 名患者接受了身体塑形手术(n = 117)。通过胃旁路术(40.1%)、胃束带术(33.9%)或袖状胃切除术(26.0%)实现减肥,平均减肥69.2公斤。最常见的塑身手术包括腹部整形术(50 例),其次是大腿提升术(29 例)、乳房整形术(19 例)、肱骨整形术(14 例)和上半身提升术(5 例)。对实验室指标的分析表明,没有发现特殊的临床相关变异。相关性分析显示,切除体重、引流液量和特定实验室指标之间存在关联:结论:无论减肥手术或塑身手术的类型如何,对大量减重后的这一特殊患者群体进行围手术期实验室指标分析,均未发现与临床相关的风险因素。事实证明,减肥干预后的身体塑形手术是安全的,而且围手术期实验室指标和术后住院风险较低。
{"title":"Analysis of laboratory markers in body contouring procedures after bariatric surgery does not indicate particular risks for perioperative complications.","authors":"Maximilian C Stumpfe, Juliane Platzer, Raymund E Horch, Alexander Geierlehner, Andreas Arkudas, Wibke Mueller-Seubert, Aijia Cai, Theresa Promny, Ingo Ludolph","doi":"10.1186/s13741-024-00422-7","DOIUrl":"https://doi.org/10.1186/s13741-024-00422-7","url":null,"abstract":"<p><strong>Background: </strong>Body contouring surgery after massive weight loss is associated with different risk factors. Wound healing disorders and seromas commonly occur postoperatively. Bariatric interventions lead to massive weight loss with excess skin and soft tissue. In this study, perioperatively collected laboratory markers of this special patient population were analyzed.</p><p><strong>Methods: </strong>Fifty-nine patients were analyzed retrospectively regarding bariatric surgery, weight loss, body contouring surgery, laboratory markers, and complication rates.</p><p><strong>Results: </strong>Body contouring surgery (n = 117) was performed in 59 patients. Weight loss was achieved after gastric bypass (40.1%), gastric banding (33.9%), or sleeve gastrectomy (26.0%), with an average of 69.2 kg. The most common body contouring procedure included abdominoplasty (n = 50), followed by thigh lift (n = 29), mammaplasty (n = 19), brachioplasty (n = 14), and upper body lift (n = 5). Analysis of laboratory markers revealed no exceptional and clinically relevant variations. Correlation analysis revealed associations between resection weight, amount of drain fluid, and particular laboratory markers.</p><p><strong>Conclusion: </strong>Analysis of perioperative laboratory markers in this special patient population after massive weight loss did not indicate clinically relevant risk factors regardless of the type of bariatric or body contouring surgery. Body contouring surgeries after bariatric interventions prove to be safe and low risk concerning perioperative laboratory markers and postoperative hospitalization.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"63"},"PeriodicalIF":2.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11210174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141469929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial profile and antibiotic susceptibility patterns in patients with secondary peritonitis: a cross-sectional study in Uganda. 继发性腹膜炎患者的细菌特征和抗生素敏感性模式:乌干达的一项横断面研究。
IF 2 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-24 DOI: 10.1186/s13741-024-00425-4
Nyenke Bassara Godefroy, Joshua Muhumuza, Selamo Fabrice Molen, Musa Abbas Waziri, ByaMungu Pahari Kagenderezo, Bienfait Mumbere Vahwere, Frank Katembo Sikakulya, William Mauricio, Joel Wandabwa, Bisingurege Kagoro Francois, Ezera Agwu, Xaviour Francis Okedi

Introduction: Secondary peritonitis is the second leading cause of sepsis worldwide. Drug resistance to peritoneal cavity bacterial infection remains a public health threat, especially in resource-limited settings in Africa, including Uganda. This study aimed to determine the antibacterial susceptibility patterns and factors associated with secondary peritonitis among patients with acute abdomen who underwent surgery at a Regional Referral Hospital in Uganda.

Methods: This was a cross-sectional study conducted at Hoima Regional Referral Hospital (HRRH) that enrolled 126 patients with acute abdomen. Clinical samples were aseptically collected at laparotomy from patients with secondary peritonitis for culture and sensitivity using standard Microbiological methods. Binary logistic regression was used to identify factors associated with secondary peritonitis among patients with acute abdomen.

Results: The majority of the patients were males (61.9%) with a mean age of 37.9(SD ± 21.8). Secondary peritonitis was found in 57(45.2%) of the patients. Gram-negative bacteria were the most commonly isolated organisms with Escherichia coli (35.8%) and Klebsiella spp (17.0%) predominating. Imipenem 88.8%(8/9), Amikacin 88.8%(8/9), Ciprofloxacin 44.4%(4/9) and Gentamicin 44.4%(4/9) demonstrated sensitivity to the different isolated organisms at varying degrees. Being a male (AOR = 3.658; 95% CI = 1.570-8.519, p = 0.003) and presenting 3 days after onset of symptoms (AOR = 2.957; 95% CI = 1.232-7.099, p = 0.015) were independently associated with secondary peritonitis.

Conclusion: Imipenem, Amikacin, Ciprofloxacin, and Gentamicin should be considered for empirical therapy in cases of secondary peritonitis. Patients, more especially males with abdominal pain should be encouraged to present early to the hospital to minimize progression to secondary peritonitis.

简介继发性腹膜炎是全球败血症的第二大病因。腹腔细菌感染的耐药性仍然是一个公共卫生威胁,尤其是在包括乌干达在内的资源有限的非洲地区。本研究旨在确定在乌干达一家地区转诊医院接受手术的急腹症患者的抗菌药敏感性模式以及与继发性腹膜炎相关的因素:这是一项在霍伊马地区转诊医院(HRRH)进行的横断面研究,共招募了126名急腹症患者。在对继发性腹膜炎患者进行开腹手术时无菌采集临床样本,采用标准微生物学方法进行培养和药敏试验。采用二元逻辑回归法确定与急腹症患者继发性腹膜炎相关的因素:结果:大多数患者为男性(61.9%),平均年龄为 37.9 岁(SD ± 21.8)。57例(45.2%)患者出现继发性腹膜炎。革兰氏阴性菌是最常见的分离菌,其中以大肠埃希菌(35.8%)和克雷伯氏菌(17.0%)为主。亚胺培南(88.8%(8/9))、阿米卡星(88.8%(8/9))、环丙沙星(44.4%(4/9))和庆大霉素(44.4%(4/9))对不同的分离菌具有不同程度的敏感性。男性(AOR = 3.658; 95% CI = 1.570-8.519, p = 0.003)和发病后 3 天就诊(AOR = 2.957; 95% CI = 1.232-7.099, p = 0.015)与继发性腹膜炎独立相关:结论:亚胺培南、阿米卡星、环丙沙星和庆大霉素应作为继发性腹膜炎的经验疗法。应鼓励患者,尤其是腹痛的男性患者尽早到医院就诊,以尽量减少继发性腹膜炎的发展。
{"title":"Bacterial profile and antibiotic susceptibility patterns in patients with secondary peritonitis: a cross-sectional study in Uganda.","authors":"Nyenke Bassara Godefroy, Joshua Muhumuza, Selamo Fabrice Molen, Musa Abbas Waziri, ByaMungu Pahari Kagenderezo, Bienfait Mumbere Vahwere, Frank Katembo Sikakulya, William Mauricio, Joel Wandabwa, Bisingurege Kagoro Francois, Ezera Agwu, Xaviour Francis Okedi","doi":"10.1186/s13741-024-00425-4","DOIUrl":"10.1186/s13741-024-00425-4","url":null,"abstract":"<p><strong>Introduction: </strong>Secondary peritonitis is the second leading cause of sepsis worldwide. Drug resistance to peritoneal cavity bacterial infection remains a public health threat, especially in resource-limited settings in Africa, including Uganda. This study aimed to determine the antibacterial susceptibility patterns and factors associated with secondary peritonitis among patients with acute abdomen who underwent surgery at a Regional Referral Hospital in Uganda.</p><p><strong>Methods: </strong>This was a cross-sectional study conducted at Hoima Regional Referral Hospital (HRRH) that enrolled 126 patients with acute abdomen. Clinical samples were aseptically collected at laparotomy from patients with secondary peritonitis for culture and sensitivity using standard Microbiological methods. Binary logistic regression was used to identify factors associated with secondary peritonitis among patients with acute abdomen.</p><p><strong>Results: </strong>The majority of the patients were males (61.9%) with a mean age of 37.9(SD ± 21.8). Secondary peritonitis was found in 57(45.2%) of the patients. Gram-negative bacteria were the most commonly isolated organisms with Escherichia coli (35.8%) and Klebsiella spp (17.0%) predominating. Imipenem 88.8%(8/9), Amikacin 88.8%(8/9), Ciprofloxacin 44.4%(4/9) and Gentamicin 44.4%(4/9) demonstrated sensitivity to the different isolated organisms at varying degrees. Being a male (AOR = 3.658; 95% CI = 1.570-8.519, p = 0.003) and presenting 3 days after onset of symptoms (AOR = 2.957; 95% CI = 1.232-7.099, p = 0.015) were independently associated with secondary peritonitis.</p><p><strong>Conclusion: </strong>Imipenem, Amikacin, Ciprofloxacin, and Gentamicin should be considered for empirical therapy in cases of secondary peritonitis. Patients, more especially males with abdominal pain should be encouraged to present early to the hospital to minimize progression to secondary peritonitis.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"62"},"PeriodicalIF":2.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11197276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative capacity and contextual challenges in teaching hospitals of southern Ethiopia: explanatory sequential mixed-methods research. 埃塞俄比亚南部教学医院围手术期的能力和环境挑战:解释性顺序混合方法研究。
IF 2 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-22 DOI: 10.1186/s13741-024-00423-6
Hailemariam Mulugeta, Abebayehu Zemedkun, Getachew Mergia, Semagn M Abate, Mintesnot Gebremariam, Bedru Jemal, Getachew Nenko, Genet Gebremichael, Aschalew Besha, Mekonnen B Aregu

Background: Previous Ethiopian literature on surgical capacity and challenges has focused on quantitative investigations, lacking contextual understanding. This explanatory sequential mixed-methods research (MMR) aimed to assess perioperative capacity and contextual challenges at three teaching hospitals in southern Ethiopia.

Methods: A quantitative survey assessed workforce, infrastructure, service delivery, financing, and information systems. The survey findings were explained by qualitative semi-structured interviews of twenty perioperative providers. Descriptive statistics were integrated with qualitative thematic analysis findings using the narrative waving approach. Key findings from both datasets were linked using a joint display table.

Results: The survey revealed shortages in the specialist workforce (with a ratio of 0.58 per 100,000 population), surgical volume (at 115 surgeries per 100,000 population), equipment, supplies, financing, and perioperative data tracking. Hospitals' radiology services and blood products were only available 25-50% of the time, while anesthetic agents and essential laboratory services were often available 51-75% of the time. Perioperative management protocols were used rarely (1-25% of the time). Over 90% of patients lack health insurance coverage. Qualitative data also revealed scarcity of perioperative resources and equipment; unaffordable perioperative costs, lack of health insurance coverage, and unforeseen expenses; poor patient safety culture and communication barriers across the perioperative continuum of care; workforce shortages, job dissatisfaction, and concerns of competence; and weak national governance, and sociopolitical turmoil, and global market volatility exacerbating local challenges. These challenges are linked to risks in quality of care and patient safety, according to clinicians.

Conclusion: The study identifies deficiencies in the health system and sociopolitical landscape affecting safe surgery conduct. It highlights the need for comprehensive health system strengthening to expand workforce, upgrade facilities, improve safety culture, resilience, and leadership to ensure timely access to essential surgery. Exploring external factors, such as the impact of national governance and sociopolitical stability on reform efforts is also essential.

背景:以前有关埃塞俄比亚外科手术能力和挑战的文献主要集中在定量调查上,缺乏对背景的了解。这项解释性顺序混合方法研究(MMR)旨在评估埃塞俄比亚南部三家教学医院的围手术期能力和背景挑战:方法:一项定量调查评估了劳动力、基础设施、服务提供、融资和信息系统。对 20 名围手术期提供者进行了半结构化定性访谈,以解释调查结果。描述性统计与定性专题分析结果相结合,采用了叙事波浪式方法。使用联合显示表将两个数据集的关键结果联系起来:调查显示,在专科医生队伍(比例为每 10 万人口 0.58 人)、手术量(每 10 万人口 115 例手术)、设备、供应品、资金和围手术期数据跟踪等方面都存在短缺。医院的放射科服务和血液制品只有 25-50% 的时间可用,而麻醉剂和基本实验室服务通常有 51-75% 的时间可用。围手术期管理规程很少使用(1-25% 的时间)。超过 90% 的患者没有医疗保险。定性数据还显示,围手术期资源和设备稀缺;围手术期费用难以承受、缺乏医疗保险和意外支出;患者安全文化差异和整个围手术期护理过程中的沟通障碍;劳动力短缺、工作不满意和对能力的担忧;国家治理薄弱、社会政治动荡和全球市场波动加剧了当地面临的挑战。临床医生认为,这些挑战与医疗质量和患者安全方面的风险有关:这项研究指出了卫生系统和社会政治环境中影响手术安全的缺陷。它强调了全面加强医疗系统的必要性,以扩大劳动力、升级设施、改善安全文化、提高应变能力和领导力,从而确保及时获得必要的外科手术。探索外部因素,如国家治理和社会政治稳定对改革工作的影响也至关重要。
{"title":"Perioperative capacity and contextual challenges in teaching hospitals of southern Ethiopia: explanatory sequential mixed-methods research.","authors":"Hailemariam Mulugeta, Abebayehu Zemedkun, Getachew Mergia, Semagn M Abate, Mintesnot Gebremariam, Bedru Jemal, Getachew Nenko, Genet Gebremichael, Aschalew Besha, Mekonnen B Aregu","doi":"10.1186/s13741-024-00423-6","DOIUrl":"10.1186/s13741-024-00423-6","url":null,"abstract":"<p><strong>Background: </strong>Previous Ethiopian literature on surgical capacity and challenges has focused on quantitative investigations, lacking contextual understanding. This explanatory sequential mixed-methods research (MMR) aimed to assess perioperative capacity and contextual challenges at three teaching hospitals in southern Ethiopia.</p><p><strong>Methods: </strong>A quantitative survey assessed workforce, infrastructure, service delivery, financing, and information systems. The survey findings were explained by qualitative semi-structured interviews of twenty perioperative providers. Descriptive statistics were integrated with qualitative thematic analysis findings using the narrative waving approach. Key findings from both datasets were linked using a joint display table.</p><p><strong>Results: </strong>The survey revealed shortages in the specialist workforce (with a ratio of 0.58 per 100,000 population), surgical volume (at 115 surgeries per 100,000 population), equipment, supplies, financing, and perioperative data tracking. Hospitals' radiology services and blood products were only available 25-50% of the time, while anesthetic agents and essential laboratory services were often available 51-75% of the time. Perioperative management protocols were used rarely (1-25% of the time). Over 90% of patients lack health insurance coverage. Qualitative data also revealed scarcity of perioperative resources and equipment; unaffordable perioperative costs, lack of health insurance coverage, and unforeseen expenses; poor patient safety culture and communication barriers across the perioperative continuum of care; workforce shortages, job dissatisfaction, and concerns of competence; and weak national governance, and sociopolitical turmoil, and global market volatility exacerbating local challenges. These challenges are linked to risks in quality of care and patient safety, according to clinicians.</p><p><strong>Conclusion: </strong>The study identifies deficiencies in the health system and sociopolitical landscape affecting safe surgery conduct. It highlights the need for comprehensive health system strengthening to expand workforce, upgrade facilities, improve safety culture, resilience, and leadership to ensure timely access to essential surgery. Exploring external factors, such as the impact of national governance and sociopolitical stability on reform efforts is also essential.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"61"},"PeriodicalIF":2.0,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141440706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome improvement for anaemia and iron deficiency in ERAS hip and knee arthroplasty: a descriptive analysis. ERAS 髋关节和膝关节置换术中贫血和缺铁情况的改善:描述性分析。
IF 2 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-21 DOI: 10.1186/s13741-024-00426-3
Christoffer Calov Jørgensen, Henrik Kehlet

Background and purpose: Preoperative anaemia including iron deficiency anaemia (IDA) is a well-established perioperative risk factor. However, most studies on iron therapy to treat IDA have been negative and few have been conducted within an enhanced recovery after surgery (ERAS) protocol. Furthermore, patients with IDA often have comorbidities not necessarily influenced by iron, but potentially influencing traditional study endpoints such as length of stay (LOS), morbidity, etc. The aim of this paper is to discuss patient-related challenges when planning outcome studies on the potential benefits of iron therapy in patients with IDA, based upon a large detailed prospective database in ERAS total hip (THA) and knee arthroplasty (TKA).

Methods: A prospective observational cohort study in ERAS THA and TKA from 2022 to 2023. Detailed complete follow-up through questionnaires and electronic medical records.

Results: Of 3655 included patients, 276 (7.6%) had IDA defined as a haemoglobin (Hb) of < 13.0 g/dL and transferrin saturation of 0.20, while 3379 had a Hb of ≥ 13.0. Patients with IDA were a median 5 years older than non-anaemics, with an increased fraction living alone (38.4% vs. 28.8%), using walking aids (54.3% vs 26.4%) and receiving home care (16.2% vs 4.7%). Fewer IDA patients were working (12.7% vs. 29.6%) and a median number of prescribed drugs was higher (10 vs. 6). Median LOS was 1 day in both IDA and non-anaemic patients, but a LOS of > 2 days occurred in 11.6% of patients with IDA vs. 4.3% in non-anaemics. The proportion with 30- or 90-day readmissions was 6.5% vs. 4.1% and. 13.4% vs6.0%, in patients with IDA and non-anaemics, respectively. However, potentially anaemia or iron deficiency-related causes of LOS > 2 days or 90-day readmissions were only 5.4% and 2.2% in patients with IDA and 1.9% and 1.0% in non-anaemics.

Conclusion: Conventional randomised trials with single or composite "hard" endpoints are at risk of being inconclusive or underpowered due to a considerable burden of other patient-related risk factors and with postoperative complications which may not be modifiable by correction of IDA per se. We will propose to gain further insights from detailed observational and mechanistic studies prior to initiating extensive randomised studies.

背景和目的:包括缺铁性贫血(IDA)在内的术前贫血是公认的围手术期风险因素。然而,大多数有关铁疗法治疗 IDA 的研究结果都是负面的,很少有研究是在术后增强恢复(ERAS)方案中进行的。此外,IDA 患者通常有合并症,这些合并症并不一定受铁的影响,但有可能影响传统的研究终点,如住院时间(LOS)、发病率等。本文旨在根据 ERAS 全髋关节置换术(THA)和膝关节置换术(TKA)的大型详细前瞻性数据库,讨论在计划对 IDA 患者进行铁治疗的潜在益处的结果研究时,与患者相关的挑战:方法:对2022年至2023年ERAS全髋关节置换术(THA)和膝关节置换术(TKA)进行前瞻性队列观察研究。通过问卷调查和电子病历进行详细完整的随访:在纳入的 3655 名患者中,276 人(7.6%)患有 IDA,定义为血红蛋白(Hb)低于 2 天的 IDA 患者占 11.6%,非 IDA 患者占 4.3%。30 天或 90 天再入院的比例分别为 6.5% 对 4.1% 和 13.4% 对 6.0%。IDA患者和非贫血患者的30天或90天再入院比例分别为6.5%对4.1%和13.4%对6.0%。然而,与贫血或缺铁有关的导致住院时间超过2天或90天后再次入院的潜在原因,在IDA患者中分别仅为5.4%和2.2%,在非贫血患者中分别为1.9%和1.0%:结论:采用单一或复合 "硬 "终点的传统随机试验有可能无法得出结论,或由于与患者相关的其他风险因素和术后并发症的巨大负担而使试验能量不足,而这些并发症可能无法通过纠正IDA本身来改变。我们将建议在启动广泛的随机研究之前,从详细的观察性研究和机理研究中获得进一步的见解。
{"title":"Outcome improvement for anaemia and iron deficiency in ERAS hip and knee arthroplasty: a descriptive analysis.","authors":"Christoffer Calov Jørgensen, Henrik Kehlet","doi":"10.1186/s13741-024-00426-3","DOIUrl":"10.1186/s13741-024-00426-3","url":null,"abstract":"<p><strong>Background and purpose: </strong>Preoperative anaemia including iron deficiency anaemia (IDA) is a well-established perioperative risk factor. However, most studies on iron therapy to treat IDA have been negative and few have been conducted within an enhanced recovery after surgery (ERAS) protocol. Furthermore, patients with IDA often have comorbidities not necessarily influenced by iron, but potentially influencing traditional study endpoints such as length of stay (LOS), morbidity, etc. The aim of this paper is to discuss patient-related challenges when planning outcome studies on the potential benefits of iron therapy in patients with IDA, based upon a large detailed prospective database in ERAS total hip (THA) and knee arthroplasty (TKA).</p><p><strong>Methods: </strong>A prospective observational cohort study in ERAS THA and TKA from 2022 to 2023. Detailed complete follow-up through questionnaires and electronic medical records.</p><p><strong>Results: </strong>Of 3655 included patients, 276 (7.6%) had IDA defined as a haemoglobin (Hb) of < 13.0 g/dL and transferrin saturation of 0.20, while 3379 had a Hb of ≥ 13.0. Patients with IDA were a median 5 years older than non-anaemics, with an increased fraction living alone (38.4% vs. 28.8%), using walking aids (54.3% vs 26.4%) and receiving home care (16.2% vs 4.7%). Fewer IDA patients were working (12.7% vs. 29.6%) and a median number of prescribed drugs was higher (10 vs. 6). Median LOS was 1 day in both IDA and non-anaemic patients, but a LOS of > 2 days occurred in 11.6% of patients with IDA vs. 4.3% in non-anaemics. The proportion with 30- or 90-day readmissions was 6.5% vs. 4.1% and. 13.4% vs6.0%, in patients with IDA and non-anaemics, respectively. However, potentially anaemia or iron deficiency-related causes of LOS > 2 days or 90-day readmissions were only 5.4% and 2.2% in patients with IDA and 1.9% and 1.0% in non-anaemics.</p><p><strong>Conclusion: </strong>Conventional randomised trials with single or composite \"hard\" endpoints are at risk of being inconclusive or underpowered due to a considerable burden of other patient-related risk factors and with postoperative complications which may not be modifiable by correction of IDA per se. We will propose to gain further insights from detailed observational and mechanistic studies prior to initiating extensive randomised studies.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"60"},"PeriodicalIF":2.0,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypotension prediction index for prevention of intraoperative hypotension in patients undergoing general anesthesia: a randomized controlled trial. 预防全身麻醉患者术中低血压的低血压预测指数:随机对照试验。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-15 DOI: 10.1186/s13741-024-00414-7
Chih-Jun Lai, Ya-Jung Cheng, Yin-Yi Han, Po-Ni Hsiao, Pei-Lin Lin, Ching-Tang Chiu, Jang-Ming Lee, Yu-Wen Tien, Kuo-Liong Chien

Background: Intraoperative hypotension is a common side effect of general anesthesia. Here we examined whether the Hypotension Prediction Index (HPI), a novel warning system, reduces the severity and duration of intraoperative hypotension during general anesthesia.

Methods: This randomized controlled trial was conducted in a tertiary referral hospital. We enrolled patients undergoing general anesthesia with invasive arterial monitoring. Patients were randomized 1:1 either to receive hemodynamic management with HPI guidance (intervention) or standard of care (control) treatment. Intraoperative hypotension treatment was initiated at HPI > 85 (intervention) or mean arterial pressure (MAP) < 65 mmHg (control). The primary outcome was hypotension severity, defined as a time-weighted average (TWA) MAP < 65 mmHg. Secondary outcomes were TWA MAP < 60 and < 55 mmHg.

Results: Of the 60 patients who completed the study, 30 were in the intervention group and 30 in the control group. The patients' median age was 62 years, and 48 of them were male. The median duration of surgery was 490 min. The median MAP before surgery presented no significant difference between the two groups. The intervention group showed significantly lower median TWA MAP < 65 mmHg than the control group (0.02 [0.003, 0.08] vs. 0.37 [0.20, 0.58], P < 0.001). Findings were similar for TWA MAP < 60 mmHg and < 55 mmHg. The median MAP during surgery was significantly higher in the intervention group than that in the control group (87.54 mmHg vs. 77.92 mmHg, P < 0.001).

Conclusions: HPI guidance appears to be effective in preventing intraoperative hypotension during general anesthesia. Further investigation is needed to assess the impact of HPI on patient outcomes.

Trial registration: ClinicalTrials.gov (NCT04966364); 202105065RINA; Date of registration: July 19, 2021; The recruitment date of the first patient: July 22, 2021.

背景:术中低血压是全身麻醉的常见副作用。在此,我们研究了低血压预测指数(HPI)这一新型预警系统能否降低全身麻醉期间术中低血压的严重程度并缩短其持续时间:这项随机对照试验在一家三级转诊医院进行。我们招募了接受有创动脉监测的全身麻醉患者。患者按 1:1 随机分配,接受 HPI 指导下的血液动力学管理(干预)或标准护理(对照)治疗。术中低血压治疗在 HPI > 85(干预)或平均动脉压 (MAP) 结果时启动:在完成研究的 60 名患者中,干预组和对照组各占 30 人。患者的中位年龄为 62 岁,其中 48 人为男性。手术时间中位数为 490 分钟。两组患者术前的中位血压无明显差异。结论:HPI 引导似乎能有效预防全身麻醉期间的术中低血压。需要进一步调查以评估 HPI 对患者预后的影响:试验注册:ClinicalTrials.gov (NCT04966364);202105065RINA;注册日期:2021年7月19日:注册日期:2021年7月19日;首例患者招募日期:2021年7月22日:首例患者招募日期:2021 年 7 月 22 日。
{"title":"Hypotension prediction index for prevention of intraoperative hypotension in patients undergoing general anesthesia: a randomized controlled trial.","authors":"Chih-Jun Lai, Ya-Jung Cheng, Yin-Yi Han, Po-Ni Hsiao, Pei-Lin Lin, Ching-Tang Chiu, Jang-Ming Lee, Yu-Wen Tien, Kuo-Liong Chien","doi":"10.1186/s13741-024-00414-7","DOIUrl":"10.1186/s13741-024-00414-7","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative hypotension is a common side effect of general anesthesia. Here we examined whether the Hypotension Prediction Index (HPI), a novel warning system, reduces the severity and duration of intraoperative hypotension during general anesthesia.</p><p><strong>Methods: </strong>This randomized controlled trial was conducted in a tertiary referral hospital. We enrolled patients undergoing general anesthesia with invasive arterial monitoring. Patients were randomized 1:1 either to receive hemodynamic management with HPI guidance (intervention) or standard of care (control) treatment. Intraoperative hypotension treatment was initiated at HPI > 85 (intervention) or mean arterial pressure (MAP) < 65 mmHg (control). The primary outcome was hypotension severity, defined as a time-weighted average (TWA) MAP < 65 mmHg. Secondary outcomes were TWA MAP < 60 and < 55 mmHg.</p><p><strong>Results: </strong>Of the 60 patients who completed the study, 30 were in the intervention group and 30 in the control group. The patients' median age was 62 years, and 48 of them were male. The median duration of surgery was 490 min. The median MAP before surgery presented no significant difference between the two groups. The intervention group showed significantly lower median TWA MAP < 65 mmHg than the control group (0.02 [0.003, 0.08] vs. 0.37 [0.20, 0.58], P < 0.001). Findings were similar for TWA MAP < 60 mmHg and < 55 mmHg. The median MAP during surgery was significantly higher in the intervention group than that in the control group (87.54 mmHg vs. 77.92 mmHg, P < 0.001).</p><p><strong>Conclusions: </strong>HPI guidance appears to be effective in preventing intraoperative hypotension during general anesthesia. Further investigation is needed to assess the impact of HPI on patient outcomes.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov (NCT04966364); 202105065RINA; Date of registration: July 19, 2021; The recruitment date of the first patient: July 22, 2021.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"57"},"PeriodicalIF":2.6,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11180403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of remimazolam versus propofol anesthesia on postoperative delirium in neurovascular surgery: study protocol for a randomized controlled, non-inferiority trial. 雷马唑仑与异丙酚麻醉对神经血管手术术后谵妄的影响:随机对照非劣效性试验的研究方案。
IF 2 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-14 DOI: 10.1186/s13741-024-00415-6
Jeayoun Kim, Seungwon Lee, Boram Park, Woo Seog Sim, Hyun Joo Ahn, Mi-Hye Park, Ji Seon Jeong

Background: Remimazolam is a short-acting benzodiazepine newly approved for the induction and maintenance of general anesthesia. Remimazolam emerges as an ideal drug for the neurosurgical population due to its rapid emergence, enabling early neurological assessment, and its ability to maintain perfusion pressure, which is crucial for preventing cerebral ischemia. However, the use of benzodiazepine has been associated with an increased risk of postoperative delirium (POD). There is currently limited evidence about the relationship between remimazolam-based total intravenous anesthesia (TIVA) and POD.

Methods: In this double-blind, randomized, non-inferiority trial, we plan to include 696 adult patients with American Society of Anesthesiologists physical status class I to III, undergoing elective neurovascular surgery under general anesthesia. After informed consent, the patients will be randomized to receive either remimazolam or propofol-based TIVA with a 1:1 ratio. The primary outcome is the incidence of POD within 5 days after surgery. Secondary outcomes include subtypes, number of positive assessments and severity of POD, emergence agitation, intraoperative awareness and undesirable patient movement, intraoperative hypotension, and postoperative cognitive function. The data will be analyzed in modified intention to treat.

Discussion: This trial will evaluate the effect of remimazolam on the development of POD compared to propofol anesthesia. The results of this trial will provide evidence regarding the choice of optimal anesthetics to minimize the risk of POD in neurosurgical patients.

Trial registration: The study protocol was prospectively registered at the Clinical trials ( https://clinicaltrials.gov , NCT06115031, principal investigator: Jiseon Jeong; date of first registration: November 2, 2023, before the recruitment of the first participant.

背景介绍雷马唑仑是一种短效苯二氮卓类药物,新近被批准用于全身麻醉的诱导和维持。雷马唑仑是神经外科患者的理想用药,因为它起效迅速,可进行早期神经评估,并能维持灌注压,这对防止脑缺血至关重要。然而,使用苯二氮卓类药物与术后谵妄(POD)风险增加有关。目前关于基于雷马唑仑的全静脉麻醉(TIVA)与 POD 之间关系的证据有限:在这项双盲、随机、非劣效试验中,我们计划纳入 696 名在全身麻醉下接受择期神经血管手术的美国麻醉医师协会体能状态 I 级至 III 级的成年患者。在获得知情同意后,患者将按 1:1 的比例随机接受瑞马唑仑或异丙酚 TIVA。主要结果是术后 5 天内 POD 的发生率。次要结果包括 POD 的亚型、阳性评估次数和严重程度、出现躁动、术中意识和患者不良动作、术中低血压和术后认知功能。数据将按修改后的意向治疗法进行分析:本试验将评估与异丙酚麻醉相比,雷马唑仑对 POD 发生的影响。该试验的结果将为神经外科患者选择最佳麻醉药以最大限度降低 POD 风险提供证据:研究方案已在临床试验网( https://clinicaltrials.gov , NCT06115031,主要研究者:Jiseon Jeong;日期:2012-2013)进行了前瞻性注册:Jiseon Jeong;首次注册日期:2023 年 11 月 2 日:首次注册日期:2023年11月2日,在招募第一名参与者之前。
{"title":"Effect of remimazolam versus propofol anesthesia on postoperative delirium in neurovascular surgery: study protocol for a randomized controlled, non-inferiority trial.","authors":"Jeayoun Kim, Seungwon Lee, Boram Park, Woo Seog Sim, Hyun Joo Ahn, Mi-Hye Park, Ji Seon Jeong","doi":"10.1186/s13741-024-00415-6","DOIUrl":"10.1186/s13741-024-00415-6","url":null,"abstract":"<p><strong>Background: </strong>Remimazolam is a short-acting benzodiazepine newly approved for the induction and maintenance of general anesthesia. Remimazolam emerges as an ideal drug for the neurosurgical population due to its rapid emergence, enabling early neurological assessment, and its ability to maintain perfusion pressure, which is crucial for preventing cerebral ischemia. However, the use of benzodiazepine has been associated with an increased risk of postoperative delirium (POD). There is currently limited evidence about the relationship between remimazolam-based total intravenous anesthesia (TIVA) and POD.</p><p><strong>Methods: </strong>In this double-blind, randomized, non-inferiority trial, we plan to include 696 adult patients with American Society of Anesthesiologists physical status class I to III, undergoing elective neurovascular surgery under general anesthesia. After informed consent, the patients will be randomized to receive either remimazolam or propofol-based TIVA with a 1:1 ratio. The primary outcome is the incidence of POD within 5 days after surgery. Secondary outcomes include subtypes, number of positive assessments and severity of POD, emergence agitation, intraoperative awareness and undesirable patient movement, intraoperative hypotension, and postoperative cognitive function. The data will be analyzed in modified intention to treat.</p><p><strong>Discussion: </strong>This trial will evaluate the effect of remimazolam on the development of POD compared to propofol anesthesia. The results of this trial will provide evidence regarding the choice of optimal anesthetics to minimize the risk of POD in neurosurgical patients.</p><p><strong>Trial registration: </strong>The study protocol was prospectively registered at the Clinical trials ( https://clinicaltrials.gov , NCT06115031, principal investigator: Jiseon Jeong; date of first registration: November 2, 2023, before the recruitment of the first participant.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"56"},"PeriodicalIF":2.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11177377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temperature effect on coagulation function in mild hypothermic patients undergoing thoracic surgeries: thromboelastography (TEG) versus standard tests. 胸外科手术中轻度低体温患者的温度对凝血功能的影响:血栓弹性成像(TEG)与标准测试对比。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-12 DOI: 10.1186/s13741-024-00405-8
Shangyi Hui, Qian Zhang, Jiaxin Lang, Jie Yi

Purpose: Our previous research has revealed that mild hypothermia leads to excessive bleeding in thoracic surgeries, while the underlying mechanism stayed unrevealed by the standard coagulation tests. The research question in this study was as follows: "How does mild hypothermia impair the hemostatic function in patients receiving thoracic surgeries?". The purpose was to detect the disturbed coagulation processes by comparing the TEG parameters in patients receiving active vs. passive warming during thoracic surgeries.

Methods: Standard coagulation tests and thromboelastography (TEG) were adopted to compare the hemostatic functions in patients receiving active vs. passive warming during thoracic surgeries. Furthermore, blood samples from passive warming group were retested for TEG at actual core body temperatures.

Results: Sixty-four eligible patients were included in this study. TEG revealed that mild hypothermia significantly disturbed coagulation by decreasing MA (59.4 ± 4.5 mm vs. 64.2 ± 5.7 mm, p = 0.04) and α angle (70.4 ± 5.2° vs. 74.9 ± 4.4°, p = 0.05) and prolonging ACT (122.2 ± 19.3 s vs. 117.3 ± 15.2 s, p = 0.01) and K time (1.9 ± 1.0 s vs. 1.3 ± 0.4 min, p = 0.02). TEGs conducted under core body temperatures revealed more impaired coagulation than those incubated at 37 °C. Furthermore, postoperative shivering and waking time were significantly increased in mild hypothermic patients.

Conclusion: Mild hypothermia significantly impaired coagulation function in patients receiving thoracic surgeries, which could be detected by TEGs other than the standard coagulation tests. Temperature-adjusted TEGs may provide a preferable method of hemostatic monitoring and transfusion guidance in thoracic surgeries, which warrants further clinical investigations.

目的:我们之前的研究发现,轻度低体温会导致胸腔手术出血过多,而标准的凝血测试却无法揭示其根本机制。本研究的问题如下:"轻度低体温如何损害胸外科手术患者的止血功能?目的是通过比较胸外科手术期间接受主动加温和被动加温的患者的 TEG 参数,检测凝血过程是否受到干扰:方法:采用标准凝血测试和血栓弹力图(TEG)来比较胸外科手术中主动与被动保暖患者的止血功能。此外,被动保暖组的血液样本在实际核心体温下重新进行了 TEG 检测:本研究共纳入 64 名符合条件的患者。TEG显示,轻度低体温会显著干扰凝血功能,降低MA(59.4 ± 4.5 mm vs. 64.2 ± 5.7 mm,p = 0.04)和α角(70.4 ± 5.2° vs. 74.9 ± 4.4°,p = 0.04)。74.9 ± 4.4°,p = 0.05)和延长 ACT(122.2 ± 19.3 秒 vs. 117.3 ± 15.2 秒,p = 0.01)和 K 时间(1.9 ± 1.0 秒 vs. 1.3 ± 0.4 分钟,p = 0.02)。在核心体温下进行的 TEG 比在 37 °C 下培养的 TEG 显示出更严重的凝血功能受损。此外,轻度低体温患者术后哆嗦和苏醒时间明显增加:结论:轻度低体温会明显损害胸外科手术患者的凝血功能,这可以通过标准凝血测试以外的 TEG 检测出来。温度调整型 TEG 可为胸外科手术中的止血监测和输血指导提供一种更好的方法,值得临床进一步研究。
{"title":"Temperature effect on coagulation function in mild hypothermic patients undergoing thoracic surgeries: thromboelastography (TEG) versus standard tests.","authors":"Shangyi Hui, Qian Zhang, Jiaxin Lang, Jie Yi","doi":"10.1186/s13741-024-00405-8","DOIUrl":"10.1186/s13741-024-00405-8","url":null,"abstract":"<p><strong>Purpose: </strong>Our previous research has revealed that mild hypothermia leads to excessive bleeding in thoracic surgeries, while the underlying mechanism stayed unrevealed by the standard coagulation tests. The research question in this study was as follows: \"How does mild hypothermia impair the hemostatic function in patients receiving thoracic surgeries?\". The purpose was to detect the disturbed coagulation processes by comparing the TEG parameters in patients receiving active vs. passive warming during thoracic surgeries.</p><p><strong>Methods: </strong>Standard coagulation tests and thromboelastography (TEG) were adopted to compare the hemostatic functions in patients receiving active vs. passive warming during thoracic surgeries. Furthermore, blood samples from passive warming group were retested for TEG at actual core body temperatures.</p><p><strong>Results: </strong>Sixty-four eligible patients were included in this study. TEG revealed that mild hypothermia significantly disturbed coagulation by decreasing MA (59.4 ± 4.5 mm vs. 64.2 ± 5.7 mm, p = 0.04) and α angle (70.4 ± 5.2° vs. 74.9 ± 4.4°, p = 0.05) and prolonging ACT (122.2 ± 19.3 s vs. 117.3 ± 15.2 s, p = 0.01) and K time (1.9 ± 1.0 s vs. 1.3 ± 0.4 min, p = 0.02). TEGs conducted under core body temperatures revealed more impaired coagulation than those incubated at 37 °C. Furthermore, postoperative shivering and waking time were significantly increased in mild hypothermic patients.</p><p><strong>Conclusion: </strong>Mild hypothermia significantly impaired coagulation function in patients receiving thoracic surgeries, which could be detected by TEGs other than the standard coagulation tests. Temperature-adjusted TEGs may provide a preferable method of hemostatic monitoring and transfusion guidance in thoracic surgeries, which warrants further clinical investigations.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"55"},"PeriodicalIF":2.6,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141311270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemolysis during open heart surgery in patients with hereditary spherocytosis - systematic review of the literature and case study. 遗传性球形红细胞增多症患者开放性心脏手术中的溶血--文献系统回顾与病例研究。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-10 DOI: 10.1186/s13741-024-00411-w
Konrad Mendrala, Tomasz Czober, Tomasz Darocha, Damian Hudziak, Paweł Podsiadło, Sylweriusz Kosiński, Bogusz Jagoda, Radosław Gocoł

Background: Due to the distinctive nature of cardiac surgery, patients suffering from hereditary spherocytosis (HS) are potentially at a high risk of perioperative complications resulting from hemolysis. Despite being the most prevalent cause of hereditary chronic hemolysis, the standards of surgical management are based solely on expert opinion.

Objective: We analyze the risk of hemolysis in HS patients after cardiac surgery based on a systematic review of the literature. We also describe a case of a patient with hereditary spherocytosis who underwent aortic valve repair.

Methods: This systematic review was registered in the PROSPERO international prospective register of systematic reviews (CRD42023417666) and included records from Embase, MEDLINE, Web of Science, and Google Scholar databases. The case study investigates a 38-year-old patient who underwent surgery for an aortic valve defect in mid-2022.

Results: Of the 787 search results, 21 studies describing 23 cases of HS undergoing cardiac surgery were included in the final analysis. Hemolysis was diagnosed in five patients (one coronary artery bypass graft surgery, two aortic valve bioprosthesis, one ventricular septal defect closure, and one mitral valve plasty). None of the patients died in the perioperative period. Also, no significant clinical hemolysis was observed in our patient during the perioperative period.

Conclusions: The literature data show that hemolysis is not common in patients with HS undergoing various cardiac surgery techniques. The typical management of a patient with mild/moderate HS does not appear to increase the risk of significant clinical hemolysis. Commonly accepted beliefs about factors inducing hemolysis during cardiac surgery may not be fully justified and require further investigation.

背景:由于心脏手术的特殊性,遗传性球形红细胞增多症(HS)患者在围手术期因溶血而出现并发症的风险很高。尽管该病是遗传性慢性溶血的最常见病因,但手术治疗的标准仅以专家意见为依据:我们在系统回顾文献的基础上分析了 HS 患者在心脏手术后发生溶血的风险。我们还描述了一例接受主动脉瓣修复手术的遗传性球形红细胞增多症患者:本系统综述在 PROSPERO 国际前瞻性系统综述注册系统(CRD42023417666)中注册,包括 Embase、MEDLINE、Web of Science 和 Google Scholar 数据库中的记录。该病例研究调查了一位在2022年中期接受主动脉瓣缺损手术的38岁患者:在 787 项搜索结果中,有 21 项研究对 23 例接受心脏手术的 HS 病例进行了最终分析。5例患者被诊断为溶血(1例冠状动脉旁路移植手术、2例主动脉瓣生物修复术、1例室间隔缺损封堵术和1例二尖瓣成形术)。所有患者均未在围手术期死亡。此外,我们的患者在围手术期也未观察到明显的临床溶血现象:文献数据显示,在接受各种心脏手术的 HS 患者中,溶血并不常见。对轻度/中度 HS 患者的典型处理方法似乎不会增加发生严重临床溶血的风险。对于心脏手术中诱发溶血的因素,人们普遍接受的观点可能并不完全正确,需要进一步研究。
{"title":"Hemolysis during open heart surgery in patients with hereditary spherocytosis - systematic review of the literature and case study.","authors":"Konrad Mendrala, Tomasz Czober, Tomasz Darocha, Damian Hudziak, Paweł Podsiadło, Sylweriusz Kosiński, Bogusz Jagoda, Radosław Gocoł","doi":"10.1186/s13741-024-00411-w","DOIUrl":"10.1186/s13741-024-00411-w","url":null,"abstract":"<p><strong>Background: </strong>Due to the distinctive nature of cardiac surgery, patients suffering from hereditary spherocytosis (HS) are potentially at a high risk of perioperative complications resulting from hemolysis. Despite being the most prevalent cause of hereditary chronic hemolysis, the standards of surgical management are based solely on expert opinion.</p><p><strong>Objective: </strong>We analyze the risk of hemolysis in HS patients after cardiac surgery based on a systematic review of the literature. We also describe a case of a patient with hereditary spherocytosis who underwent aortic valve repair.</p><p><strong>Methods: </strong>This systematic review was registered in the PROSPERO international prospective register of systematic reviews (CRD42023417666) and included records from Embase, MEDLINE, Web of Science, and Google Scholar databases. The case study investigates a 38-year-old patient who underwent surgery for an aortic valve defect in mid-2022.</p><p><strong>Results: </strong>Of the 787 search results, 21 studies describing 23 cases of HS undergoing cardiac surgery were included in the final analysis. Hemolysis was diagnosed in five patients (one coronary artery bypass graft surgery, two aortic valve bioprosthesis, one ventricular septal defect closure, and one mitral valve plasty). None of the patients died in the perioperative period. Also, no significant clinical hemolysis was observed in our patient during the perioperative period.</p><p><strong>Conclusions: </strong>The literature data show that hemolysis is not common in patients with HS undergoing various cardiac surgery techniques. The typical management of a patient with mild/moderate HS does not appear to increase the risk of significant clinical hemolysis. Commonly accepted beliefs about factors inducing hemolysis during cardiac surgery may not be fully justified and require further investigation.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"54"},"PeriodicalIF":2.6,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141301288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioid-sparing effects of ultrasound-guided erector spinae plane block for video-assisted thoracoscopic surgery: a randomized controlled study. 视频辅助胸腔镜手术中超声引导竖脊肌平面阻滞的阿片类药物保留效果:随机对照研究。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-07 DOI: 10.1186/s13741-024-00413-8
Huan Xu, Wei Wu, Xue Chen, Wenxin He, Hong Shi

Background: The erector spinae plane block (ESPB) is a new analgesic method used in thoracic surgery. However, few studies have characterized their effects on perioperative opioid consumption. We aimed to evaluate the effects of ESPB on perioperative opioid consumption in patients who underwent video-assisted thoracoscopic surgery (VATS).

Methods: This was a randomized, observer-blinded clinical trial at a single-centre academic hospital. Eighty patients were scheduled for thoracoscopic segmentectomy or lobectomy by VATS for lung cancer. Forty participants were randomly assigned to ESPB or control group. All patients received intravenous patient-controlled postoperative analgesia. Perioperative opioid consumption, visual analogue scale (VAS) scores, and adverse events were recorded.

Results: Intraoperative and postoperative opioid consumption and static/dynamic VAS scores were significantly lower in the early hours after VATS in the ESPB group (p < 0.05) than the control group. No significant differences were observed in adverse effects between the two groups.

Conclusions: ESPB reduced intraoperative opioid consumption and early postoperative pain in patients undergoing VATS. Our findings support the view that ESPB is a safe and highly effective option for regional analgesia for VATS.

Trial registration: http://www.chictr.org.cn , ChiCTR1800019335.

背景:竖脊肌平面阻滞(ESPB)是胸外科手术中一种新的镇痛方法。然而,很少有研究描述其对围术期阿片类药物消耗量的影响。我们旨在评估 ESPB 对接受视频辅助胸腔镜手术(VATS)患者围手术期阿片类药物消耗量的影响:这是一项在单中心学术医院进行的随机、观察者盲法临床试验。80名肺癌患者计划接受胸腔镜肺段切除术或VATS肺叶切除术。40 名参与者被随机分配到 ESPB 或对照组。所有患者均接受静脉注射患者自控术后镇痛。对围手术期阿片类药物消耗量、视觉模拟量表(VAS)评分和不良反应进行了记录:结果:ESPB 组患者在 VATS 术后早期的术中和术后阿片类药物消耗量以及静态/动态 VAS 评分均明显降低(p 结论:ESPB 可减少术中阿片类药物消耗量和术后 VAS 评分:ESPB减少了VATS患者术中阿片类药物的用量和术后早期疼痛。我们的研究结果支持ESPB是一种安全、高效的VATS区域镇痛选择的观点。试验注册: http://www.chictr.org.cn , ChiCTR1800019335。
{"title":"Opioid-sparing effects of ultrasound-guided erector spinae plane block for video-assisted thoracoscopic surgery: a randomized controlled study.","authors":"Huan Xu, Wei Wu, Xue Chen, Wenxin He, Hong Shi","doi":"10.1186/s13741-024-00413-8","DOIUrl":"10.1186/s13741-024-00413-8","url":null,"abstract":"<p><strong>Background: </strong>The erector spinae plane block (ESPB) is a new analgesic method used in thoracic surgery. However, few studies have characterized their effects on perioperative opioid consumption. We aimed to evaluate the effects of ESPB on perioperative opioid consumption in patients who underwent video-assisted thoracoscopic surgery (VATS).</p><p><strong>Methods: </strong>This was a randomized, observer-blinded clinical trial at a single-centre academic hospital. Eighty patients were scheduled for thoracoscopic segmentectomy or lobectomy by VATS for lung cancer. Forty participants were randomly assigned to ESPB or control group. All patients received intravenous patient-controlled postoperative analgesia. Perioperative opioid consumption, visual analogue scale (VAS) scores, and adverse events were recorded.</p><p><strong>Results: </strong>Intraoperative and postoperative opioid consumption and static/dynamic VAS scores were significantly lower in the early hours after VATS in the ESPB group (p < 0.05) than the control group. No significant differences were observed in adverse effects between the two groups.</p><p><strong>Conclusions: </strong>ESPB reduced intraoperative opioid consumption and early postoperative pain in patients undergoing VATS. Our findings support the view that ESPB is a safe and highly effective option for regional analgesia for VATS.</p><p><strong>Trial registration: </strong>http://www.chictr.org.cn , ChiCTR1800019335.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"53"},"PeriodicalIF":2.6,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with early inhospital adverse outcome following surgery for acute appendicitis in Uganda: a multicenter cohort. 乌干达急性阑尾炎手术后早期住院不良后果的相关因素:多中心队列。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-03 DOI: 10.1186/s13741-024-00412-9
Sharif Yusuf Farhan, Demoz Abraha, Isaac Edyedu, Selamo Fabrice Molen, William Mauricio, Samuel Oledo Odong, Michael Mugeni, Joshua Muhumuza

Introduction: Surgery for acute appendicitis has been associated with significant morbidity. This study aimed to determine the factors associated with early inhospital adverse outcomes following surgery for acute appendicitis in Uganda.

Methods: This was a multicentre, prospective cohort in which early inhospital outcome following surgery for acute appendicitis was assessed at 4 regional referral hospitals in Uganda. The occurrence of complications during the admission period was documented as well as the length of hospital stay. Factors associated with adverse outcomes were determined using Poisson regression.

Results: Of the 102 patients who underwent surgery for acute appendicitis, the majority were males 79(77.5%) with a mean age of 23.8(SD = 12.5) years. The perforated appendix was seen in 26 (25.5%) patients. Post-operative complications occurred in 21(20.6%) with the commonest being surgical site infection in 19(18.6%) patients. The median length of hospital stay was 3(IQR = 3-4) days with 43(42.2%) staying in hospital for more than 3 days. The presence of anemia (Hb < 8) (aRR = 1.376, CI = 1.159-1.634, P =  < 0.001) and having a perforated appendix (aRR = 1.263, CI = 1.026-1.555, P = 0.027) were independently associated with occurrence of complications while being HIV positive (aRR = 1.379, CI = 1.105-1.721, P = 0.005) and having a perforated appendix (aRR = 1.258, CI = 1.019-1.554, P = 0.033) were independently associated with prolonged hospital stay.

Conclusion: Community education about early presentation is still required in order to reduce the number of patients that present late which should, in turn, reduce the risk of complications and length of hospital stay.

简介:急性阑尾炎手术与严重的发病率有关。本研究旨在确定乌干达急性阑尾炎手术后早期住院不良后果的相关因素:这是一项多中心前瞻性队列研究,在乌干达的 4 家地区转诊医院对急性阑尾炎手术后的早期院内不良后果进行了评估。入院期间发生的并发症以及住院时间都被记录在案。采用泊松回归法确定了与不良后果相关的因素:在 102 名接受急性阑尾炎手术的患者中,男性占 79 人(77.5%),平均年龄为 23.8 岁(SD = 12.5)。26例(25.5%)患者出现阑尾穿孔。21例(20.6%)患者出现术后并发症,其中最常见的是19例(18.6%)患者的手术部位感染。住院时间中位数为 3 天(IQR = 3-4),其中 43 人(42.2%)住院时间超过 3 天。贫血(Hb仍需开展有关早期就诊的社区教育,以减少晚期就诊的患者人数,进而降低并发症风险并缩短住院时间。
{"title":"Factors associated with early inhospital adverse outcome following surgery for acute appendicitis in Uganda: a multicenter cohort.","authors":"Sharif Yusuf Farhan, Demoz Abraha, Isaac Edyedu, Selamo Fabrice Molen, William Mauricio, Samuel Oledo Odong, Michael Mugeni, Joshua Muhumuza","doi":"10.1186/s13741-024-00412-9","DOIUrl":"10.1186/s13741-024-00412-9","url":null,"abstract":"<p><strong>Introduction: </strong>Surgery for acute appendicitis has been associated with significant morbidity. This study aimed to determine the factors associated with early inhospital adverse outcomes following surgery for acute appendicitis in Uganda.</p><p><strong>Methods: </strong>This was a multicentre, prospective cohort in which early inhospital outcome following surgery for acute appendicitis was assessed at 4 regional referral hospitals in Uganda. The occurrence of complications during the admission period was documented as well as the length of hospital stay. Factors associated with adverse outcomes were determined using Poisson regression.</p><p><strong>Results: </strong>Of the 102 patients who underwent surgery for acute appendicitis, the majority were males 79(77.5%) with a mean age of 23.8(SD = 12.5) years. The perforated appendix was seen in 26 (25.5%) patients. Post-operative complications occurred in 21(20.6%) with the commonest being surgical site infection in 19(18.6%) patients. The median length of hospital stay was 3(IQR = 3-4) days with 43(42.2%) staying in hospital for more than 3 days. The presence of anemia (Hb < 8) (aRR = 1.376, CI = 1.159-1.634, P =  < 0.001) and having a perforated appendix (aRR = 1.263, CI = 1.026-1.555, P = 0.027) were independently associated with occurrence of complications while being HIV positive (aRR = 1.379, CI = 1.105-1.721, P = 0.005) and having a perforated appendix (aRR = 1.258, CI = 1.019-1.554, P = 0.033) were independently associated with prolonged hospital stay.</p><p><strong>Conclusion: </strong>Community education about early presentation is still required in order to reduce the number of patients that present late which should, in turn, reduce the risk of complications and length of hospital stay.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"51"},"PeriodicalIF":2.6,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Perioperative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1